pentobarbital has been researched along with Puerperal Disorders in 2 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
Puerperal Disorders: Disorders or diseases associated with PUERPERIUM, the six-to-eight-week period immediately after PARTURITION in humans.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caseby, NG | 1 |
| Lewis, CJ | 1 |
| Oakley, GA | 1 |
2 other studies available for pentobarbital and Puerperal Disorders
| Article | Year |
|---|---|
Postpartum stroke successfully treated with high-dose pentobarbitone therapy: a case report.
Topics: Adult; Cerebrovascular Disorders; Female; Humans; Infusions, Parenteral; Intracranial Pressure; Pent | 1983 |
Treatment of puerperal psychosis in sows by sedative and anaesthetic drugs.
Topics: Anesthetics; Animals; Behavior, Animal; Chlorpromazine; Female; Injections, Intravenous; Pentobarbit | 1970 |